Atea Pharmaceuticals AVIR
NASDAQ AVIR
$4.22 +0.02 (+0.48%)
At close: Nov 11, 2026 · 4:00 PM EST

Atea Pharmaceuticals (AVIR) Return on Sales [ROS] (2021)

Updated

Atea Pharmaceuticals' Return on Sales [ROS] was 63.06% in Q4 2021, up 130.55 percentage points from the prior quarter.

Analysis

Atea Pharmaceuticals (AVIR) Return on Sales [ROS] (2021) Analysis & Trends

For FY2021, Return on Sales [ROS] at Atea Pharmaceuticals came in at 39.38%, up 62.06 percentage points from FY2020.

  • In earlier years, Return on Sales [ROS] was -22.68% in FY2020.
  • Per Business Quant data, AVIR's Return on Sales [ROS] in the three quarters before Q4 2021 was -67.50% (Q3 2021), 14.38% (Q2 2021) and 46.46% (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Atea Pharmaceuticals 337.28 Mn -631.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 63.06%
Sep 30, 2021 -67.50%
Jun 30, 2021 14.38%
Mar 31, 2021 46.46%
API Access

Atea Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AVIR&period=max&api_key=YOUR_API_KEY